![Christopher Vann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Vann
Directeur des opérations chez
AUTOLUS THERAPEUTICS PLC
Fortune : 359 435 $ au 31/05/2026
Profil
Christopher Vann currently works at Alliance for Regenerative Medicine, as Treasurer & Director from 2023 and Autolus Therapeutics Plc, as Chief Operating Officer & Senior Vice President from 2016.
Mr. Vann also formerly worked at Roche Holding AG, as Commercial Director from 1994 to 2016.
Mr. Vann received his undergraduate degree from School of Pharmacy.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2026 | 192 211 ( 0,12% ) | 359 435 $ | 31/05/2026 |
Postes actifs de Christopher Vann
| Sociétés | Poste | Début |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Directeur des opérations | 01/10/2016 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Directeur/Membre du Conseil | 01/01/2021 |
Anciens postes connus de Christopher Vann
| Sociétés | Poste | Fin |
|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/09/2016 |
Formation de Christopher Vann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
School of Pharmacy
 School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
